Invention Grant
- Patent Title: Disubstituted phthalazine hedgehog pathway antagonists
-
Application No.: US13122212Application Date: 2009-10-22
-
Publication No.: US08404687B2Publication Date: 2013-03-26
- Inventor: Jolie Anne Bastian , Philip Arthur Hipskind , Daniel Jon Sall , Takako Wilson (nee Takakuwa)
- Applicant: Jolie Anne Bastian , Philip Arthur Hipskind , Daniel Jon Sall , Takako Wilson (nee Takakuwa)
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Danica Hostettler; John C. Demeter
- International Application: PCT/US2009/061573 WO 20091022
- International Announcement: WO2010/062507 WO 20100603
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A01N43/60 ; A61K31/495 ; C07D237/30
Abstract:
The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer.
Public/Granted literature
- US20110190304A1 DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS Public/Granted day:2011-08-04
Information query
IPC分类:
